Emerging studies suggest this peptide, a dual activator targeting both the gut-brain axis and glucose-dependent insulinotropic polypeptide , appears to offer a significant step forward for obesity https://getretatrutideaustralia.com/blog/retatrutide-vs-tirzepatide-semaglutide